Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy

JACC: Cardiovascular Interventions

Volumn 4, Issue 9, 2011, Pages 1030-1034

  Almasood, Ali ^a   Garceau, Patrick ^b   Woo, Anna ^a   Rakowski, Harry ^a   Schwartz, Leonard ^a   Overgaard, Christopher B ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

alcohol septal ablation; hypertrophic cardiomyopathy; invasive management

Indexed keywords

ALCOHOL;

ABLATION THERAPY; ADOLESCENT; ADULT; AGED; ALCOHOL SEPTAL ABLATION; AORTA PRESSURE; ARTICLE; BALLOON OCCLUSION; CORONARY ARTERY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE OUTFLOW TRACT; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ABLATION TECHNIQUES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AORTA; BALLOON OCCLUSION; BLOOD PRESSURE; CARDIOMYOPATHY, HYPERTROPHIC; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR OUTFLOW OBSTRUCTION; VENTRICULAR PRESSURE; YOUNG ADULT;

EID: 80053004386     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.06.008     Document Type: Article

References (19)

1. B.J. Maron, J.M. Gardin, J.M. Flack, S.S. Gidding, T.T. Kurosaki, and D.E. Bild Prevalence of hypertrophic cardiomyopathy in a general population of young adults Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults Circulation 92 1995 785 789
2. P. Elliott, and W.J. McKenna Hypertrophic cardiomyopathy Lancet 363 2004 1881 1891 (Pubitemid 38748646)
3. C.Y. Ho, and C.E. Seidman A contemporary approach to hypertrophic cardiomyopathy Circulation 113 2006 e858 e862
4. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320 (Pubitemid 34250486)
5. A.J. Marian, and R. Roberts Recent advances in the molecular genetics of hypertrophic cardiomyopathy Circulation 92 1995 1336 1347
6. R.A. Nishimura, and D.R. Holmes Jr. Clinical practice Hypertrophic obstructive cardiomyopathy N Engl J Med 350 2004 1320 1327 (Pubitemid 38375367)
7. S.R. Ommen, and A.J. Tajik Hypertrophic cardiomyopathy: from bedside to bench... and now back again? Circulation 104 2001 126 127 (Pubitemid 32655823)
8. M.S. Maron, I. Olivotto, and A.G. Zenovich Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction Circulation 114 2006 2232 2239 (Pubitemid 44789498)
9. E. Braunwald, C.E. Seidman, and U. Sigwart Contemporary evaluation and management of hypertrophic cardiomyopathy Circulation 106 2002 1312 1316 (Pubitemid 35021247)
10. M.A. Fifer, and G.J. Vlahakes Management of symptoms in hypertrophic cardiomyopathy Circulation 117 2008 429 439
11. R. Bhagwandeen, A. Woo, and J. Ross Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre Can J Cardiol 19 2003 912 917 (Pubitemid 37069315)
12. S.L. Mulvagh, H. Rakowski, and M.A. Vannan American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography J Am Soc Echocardiogr 21 2008 1179 1201
13. U. Sigwart, M. Grbic, A. Essinger, and J.L. Rivier L'effet aigu d'une occlusion coronarienne par ballonet de la dilatation transluminale (abstr) Schweiz Med Wochenschr 45 1982 1631
14. U. Sigwart Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Lancet 346 1995 211 214
15. H. Seggewiss, U. Gleichmann, L. Faber, D. Fassbender, H.K. Schmidt, and S. Strick Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients J Am Coll Cardiol 31 1998 252 258
16. L. Faber, P. Ziemssen, and H. Seggewiss Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring J Am Soc Echocardiogr 13 2000 1074 1079 (Pubitemid 32047829)
17. D. Monakier, A. Woo, and T. Puri Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy Am J Cardiol 94 2004 1515 1522 (Pubitemid 40268453)
18. S. Carasso, A. Woo, and H. Yang Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy J Am Soc Echocardiogr 21 2008 493 499
19. J. van Ramshorst, S.A. Mollema, and V. Delgado Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient Am J Cardiol 103 2009 1592 1597